Impax Laboratories News

Time was running out on Flomax. A key patent protecting the blockbuster drug for treating the symptoms of an enlarged prostate was expiring in little more than a year.

"It's money spent gaming the system," says Davis, of USF law school, about the pay-to-delay model between generic and brand name drug makers.

HAYWARD,A Calif. Generic drug maker Impax Labs has bought the rights to two generic drugs from Watson Pharmaceuticals and Arrow Group, which Watson recently acquired.

The Federal Trade Commission today announced a proposed consent order settling charges that Watson Pharmaceuticals, Inc.'s acquisition of Robin Hood Holdings Limited, owner of Arrow Pharmaceuticals, would have harmed consumers by eliminating future competition for important generic drugs used to treat Parkinson's disease and the side effects of ...

Watson Pharmaceuticals, Inc. today announced that the Federal Trade Commission has accepted a proposed consent order for public comment relating to Watson's pending acquisition of privately held Arrow Group and has granted early termination of the Hart Scott Rodino waiting period, thereby permitting the parties to close the transaction.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

IBM announced today that Impax Laboratories, Inc. , a technology-based specialty pharmaceutical company, is using IBM business analytics technology to gain stronger insights into their business and better predict risks and market opportunities.

In our August 2009 article titled " Treating Parkinson's Disease: Investment Opportunities and Challenges ," we reviewed some of the historical challenges associated with developing treatments for Parkinson's disease [PD] and cited reasons for optimism going forward in addition to highlighting several promising companies making progress.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/10/09, Genoptix, Inc.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 10/30/09, Impax Laboratories, Inc.

Impax Laboratories Inc. confirmed Friday it is challenging the patents on Abbott Laboratories' cholesterol drug TriCor, and that Abbott is suing Impax for patent infringement.

Irish drugmaker Shire PLC said Tuesday it settled patent lawsuits against Novartis AG's Sandoz unit, which was trying to market a generic version of Shire's attention deficit hyperactivity disorder drug Adderall XR.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Main Category: Urology / Nephrology Also Included In: Regulatory Affairs / Drug Approvals Article Date: 07 Oct 2009 Impax Laboratories, Inc.

HAYWARD,A Calif. A specialty pharmaceutical company announced the tentative approval of its benign prostatic hyperplasia treatment.

BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors has Healthcare stock news and updates to its calendar database of Clinical Trials and upcoming FDA approvals & decisions.

Impax Laboratories Inc. , coming off a 3-1/2-year-old patent settlement deal with Shire Pharmaceuticals , launched a generic version of Shire's ADHD drug Adderall XR.

REDWOOD SHORES, Calif.-- --Kensington Computer Products Group, a worldwide leader in delivering smart made simple computing accessories, today announced the appointment of Greg Av... OLDWICK, N.J.-- --A.M. Best Co.

Main Category: Pharma Industry / Biotech Industry Article Date: 22 Sep 2009 - 23:00 PDT Impax Laboratories, Inc.

Sep 21, 2009 - Impax Pharmaceuticals, the brand products division of Impax Laboratories, Inc.